The table below shows Axsome Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q3 2026
Q2 2026
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Revenue
$259.69M
$218.38M
$191.20M
$170.99M
$150.04M
$121.46M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$50.62M
$46.23M
$52.68M
$40.16M
$49.54M
$44.78M
AXSM annual revenue (10-K history)
Axsome Therapeutics, Inc. reported annual revenue of $638.50M for fiscal year 2025. That is up 65.5% from $385.69M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
